Compare RGEN & BNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | BNT |
|---|---|---|
| Founded | 1981 | 2020 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.9B |
| IPO Year | 1995 | 2020 |
| Metric | RGEN | BNT |
|---|---|---|
| Price | $178.78 | $36.76 |
| Analyst Decision | Buy | |
| Analyst Count | 22 | 0 |
| Target Price | ★ $197.95 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 9.9K |
| Earning Date | 10-27-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $12.87 | N/A |
| Revenue Next Year | $29.67 | N/A |
| P/E Ratio | $743.42 | ★ $19.14 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $35.62 |
| 52 Week High | $198.87 | $49.86 |
| Indicator | RGEN | BNT |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 31.62 |
| Support Level | $159.22 | N/A |
| Resistance Level | $188.73 | $38.66 |
| Average True Range (ATR) | 8.81 | 0.45 |
| MACD | -1.51 | 0.13 |
| Stochastic Oscillator | 52.38 | 0.00 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.